Clinical Trials Logo

Clinical Trial Summary

The proposed pilot study will assess the feasibility of transcranial alternating current stimulation (tACS) to enhance aspects of attention in people with psychotic disorders. Patients and controls will each undergo two sessions of tACS while completing a visual task. One session will be set to 2 Hz above the participant's individual alpha peak frequency (IAPF) and the other session will be set to 2 Hz below the participant's IAPF. The tACS will be applied with a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (25 cm²) applied to the back of the head. The investigator's hypothesis is that participant's will perform better on the visual task while tACS is set to 2 Hz above their IAPF, relative to tACS set to 2 Hz below their IAPF.


Clinical Trial Description

The proposed pilot study will assess the feasibility of transcranial alternating current stimulation (tACS) to enhance aspects of attention in people with psychotic disorders. If a participant agrees to participate in this research, they will be asked to visit the study site to complete the activities listed below. These study activities will take about 5.5 hours to complete. The activities can be divided into up to 3 separate sessions as needed, but all activities should be completed within approximately one week. Consent (30 minutes): The study team will review this consent form with the participant. If they agree to participate in this research, they will sign and date the consent form. They will receive a copy of the signed consent form for your records. Baseline clinical assessments (60-90 minutes): Participants will be asked to complete interviews and assessments to test their cognition and to confirm any diagnoses of psychosis or mood disorders. They will also be asked to complete a demographics questionnaire. The psychosis group will be asked to complete an additional clinical assessment and will receive additional compensation accordingly. Electroencephalogram (EEG, 120 minutes): After study staff set up the gel-filled EEG cap on the participant's head, they will be asked to complete a few tasks on the computer. tACS with Double-Flash Fusion Illusion task (90 minutes): The participant will undergo 2 runs of a computerized task while simultaneously undergoing tACS stimulation. The tACS setup involves a neoprene cap (like a swim cap) with two electrodes covered by saline-soaked sponges. The stimulation system will deliver a small amount of electrical current through the saline-soaked sponges. Each task run is expected to last about 15-20 minutes, with a 40-minute break between sessions. During this break, you will be asked to perform two computerized BrainHQ tasks that look at your auditory and visual perception. After both sessions are complete, you will complete a questionnaire about the stimulation procedure and whether you experienced any adverse effects. One tACS session will be set to 2 Hz above the participant's individual alpha peak frequency (IAPF) and the other session will be set to 2 Hz below the participant's IAPF. The tACS will be applied with a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (25 cm²) applied to the back of the head. The investigator's hypothesis is that participant's will perform better on the visual task while tACS is set to 2 Hz above their IAPF, relative to tACS set to 2 Hz below their IAPF. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04856657
Study type Interventional
Source University of Minnesota
Contact Brandon Schermitzler
Phone 612-626-0953
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date June 2021
Completion date June 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Not yet recruiting NCT04005794 - Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training N/A
Recruiting NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Recruiting NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A
Completed NCT02304432 - Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Early Phase 1
Completed NCT01412060 - A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia Phase 3
Completed NCT01222793 - Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia N/A
Active, not recruiting NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Completed NCT02868879 - Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia
Recruiting NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A